Canaccord Genuity Group started coverage on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note released on Friday, Marketbeat.com reports. The firm issued a buy rating and a $5.00 target price on the stock.
WALD has been the subject of a number of other reports. DA Davidson raised their target price on shares of Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Telsey Advisory Group reissued an “outperform” rating and set a $6.00 price objective on shares of Waldencast in a research note on Wednesday, October 9th.
Get Our Latest Research Report on WALD
Waldencast Trading Up 3.3 %
Institutional Investors Weigh In On Waldencast
A number of large investors have recently made changes to their positions in the company. Marshall Wace LLP acquired a new position in Waldencast in the 2nd quarter worth approximately $37,000. Bleakley Financial Group LLC boosted its position in shares of Waldencast by 75.2% in the third quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock worth $96,000 after buying an additional 11,288 shares during the period. Catalina Capital Group LLC purchased a new position in shares of Waldencast during the first quarter valued at $73,000. Norden Group LLC acquired a new stake in Waldencast during the 1st quarter worth about $92,000. Finally, McAdam LLC purchased a new position in Waldencast during the 3rd quarter valued at about $62,000. Institutional investors and hedge funds own 41.97% of the company’s stock.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Read More
- Five stocks we like better than Waldencast
- Canada Bond Market Holiday: How to Invest and Trade
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Profitably Trade Stocks at 52-Week Highs
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 Small Caps With Big Return Potential
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.